Metopimazine

DB13591InvestigationalSmall molecule

Metopimazine: Overview.

Mechanism: Pharmacologically active on Dopamine receptor D2
Curator reviewed
Formula / weight: C₂₂H₂₇N₃O₃S₂ · 445.6 g/mol (avg)
Code names: EXP 999 · RP 9965

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyBQDBKDMTIJBJLA-UHFFFAOYSA-NSMILESCS(=O)(=O)C1=CC=C2SC3=C(C=CC=C3)N(CCCN3CCC(CC3)C(N)=O)C2=C1

Targets

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

1Marketed productAcross 1 country and 1 labeller

1ATC codeIncluding every combination product, plus 12 drug categories

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Metopimazine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.